These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21474565)

  • 1. New insights to fibroblast growth factor 23 in kidney transplant.
    Ix JH
    J Am Soc Nephrol; 2011 May; 22(5):799-801. PubMed ID: 21474565
    [No Abstract]   [Full Text] [Related]  

  • 2. With or without the kidney: the role of FGF23 in CKD.
    Fukagawa M; Kazama JJ
    Nephrol Dial Transplant; 2005 Jul; 20(7):1295-8. PubMed ID: 15840677
    [No Abstract]   [Full Text] [Related]  

  • 3. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF-23: state of the art.
    Oliveira RB; Moysés RM
    J Bras Nefrol; 2010; 32(3):323-31. PubMed ID: 21103697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disturbance of phosphorus metabolism in chronic kidney disease].
    Komaba H; Fukagawa M
    Clin Calcium; 2009 Feb; 19(2):166-72. PubMed ID: 19182354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future?
    Komaba H; Koizumi M; Fukagawa M
    Kidney Int; 2010 Nov; 78(10):953-5. PubMed ID: 21030971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
    Evenepoel P; Meijers BK; de Jonge H; Naesens M; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1829-36. PubMed ID: 18922992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia.
    Kawarazaki H; Shibagaki Y; Shimizu H; Kawarazaki W; Ito N; Ishikawa A; Fukumoto S; Fujita T
    Clin Exp Nephrol; 2007 Sep; 11(3):255-257. PubMed ID: 17891358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23, NGAL, and Endostatin: the Predictors of Allograft Function in Renal Transplant Recipients.
    Gürlek Demirci B; Sezer S; Uyanık Yıldırım S; Kaynar Erdoğan M; Tutal E; Özdemir Ö; Orazbayev G; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):136-139. PubMed ID: 29528011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.
    Seifert ME; Ashoor IF; Chiang ML; Chishti AS; Dietzen DJ; Gipson DS; Janjua HS; Selewski DT; Hruska KA
    Pediatr Transplant; 2016 May; 20(3):378-87. PubMed ID: 26880121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen IV is upregulated in chronic transplant nephropathy.
    Kawase T; Shimizu A; Adachi E; Tojimbara T; Nakajima I; Fuchinoue S; Sawada T
    Transplant Proc; 2001; 33(1-2):1207-8. PubMed ID: 11267260
    [No Abstract]   [Full Text] [Related]  

  • 12. Second chances in mineral metabolism.
    Wolf M
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):1-3. PubMed ID: 20007676
    [No Abstract]   [Full Text] [Related]  

  • 13. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ; Toussaint ND; Polkinghorne KR
    Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 23 in Postrenal Transplant: An Often Forgotten Hormone.
    Amiri FS; Khatami MR
    Exp Clin Transplant; 2016 Dec; 14(6):606-616. PubMed ID: 27934558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibroblast growth factor 23 in renal disease.
    Jonsson KB
    Nephrol Dial Transplant; 2005 Mar; 20(3):479-82. PubMed ID: 15735238
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [FGF23 in chronic kidney disease and kidney post-transplant patients].
    Negri A
    Nefrologia; 2009; 29(3):196-202. PubMed ID: 19554051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspect of recent progress in phosphate metabolism. Pathophysiology of secondary hyperparathyroidism in chronic kidney disease].
    Goto S; Fukagawa M
    Clin Calcium; 2009 Jun; 19(6):809-14. PubMed ID: 19483275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bone-renal axis in early chronic kidney disease: an emerging paradigm.
    Danziger J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2733-7. PubMed ID: 18469306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.